1. Home
  2. CPIX vs COCP Comparison

CPIX vs COCP Comparison

Compare CPIX & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • COCP
  • Stock Information
  • Founded
  • CPIX 1999
  • COCP N/A
  • Country
  • CPIX United States
  • COCP United States
  • Employees
  • CPIX N/A
  • COCP N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • COCP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPIX Health Care
  • COCP Health Care
  • Exchange
  • CPIX Nasdaq
  • COCP Nasdaq
  • Market Cap
  • CPIX 17.2M
  • COCP 18.3M
  • IPO Year
  • CPIX 2009
  • COCP N/A
  • Fundamental
  • Price
  • CPIX $2.36
  • COCP $1.99
  • Analyst Decision
  • CPIX
  • COCP Strong Buy
  • Analyst Count
  • CPIX 0
  • COCP 1
  • Target Price
  • CPIX N/A
  • COCP $7.00
  • AVG Volume (30 Days)
  • CPIX 5.5M
  • COCP 14.9K
  • Earning Date
  • CPIX 11-07-2024
  • COCP 11-13-2024
  • Dividend Yield
  • CPIX N/A
  • COCP N/A
  • EPS Growth
  • CPIX N/A
  • COCP N/A
  • EPS
  • CPIX N/A
  • COCP N/A
  • Revenue
  • CPIX $36,785,442.00
  • COCP N/A
  • Revenue This Year
  • CPIX N/A
  • COCP N/A
  • Revenue Next Year
  • CPIX N/A
  • COCP N/A
  • P/E Ratio
  • CPIX N/A
  • COCP N/A
  • Revenue Growth
  • CPIX N/A
  • COCP N/A
  • 52 Week Low
  • CPIX $1.04
  • COCP $1.33
  • 52 Week High
  • CPIX $3.05
  • COCP $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 66.16
  • COCP 51.27
  • Support Level
  • CPIX $2.07
  • COCP $1.83
  • Resistance Level
  • CPIX $2.93
  • COCP $2.07
  • Average True Range (ATR)
  • CPIX 0.26
  • COCP 0.11
  • MACD
  • CPIX 0.08
  • COCP -0.01
  • Stochastic Oscillator
  • CPIX 53.06
  • COCP 44.74

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: